Stock-based compensation accounting is governed by ASC 718. A company measures each equity award at its grant-date fair value, then recognizes that value as an expense over the vesting period, usually straight-line. The expense is non-cash, so it is added back on the cash flow statement, but it reduces GAAP net income like any other cost.
That is the whole framework in three sentences. What the textbooks and Big 4 handbooks rarely explain is the part founders actually need: when a startup has to start booking this expense, what the journal entry does to reported burn, and what a real expense schedule looks like for a standard four-year grant. This guide covers that version.
Why Startups Suddenly Care About Stock Comp Expense
Most early-stage companies grant options for years without recording a dollar of expense. The grants live in the cap table software, the board approves them, and the ledger never hears about it. Nothing forces the issue until one of three events shows up.
The first is a financial statement audit. The moment a startup needs audited GAAP financials, whether for a lender, a large customer, or an investor requirement, the auditors will ask for the stock compensation expense schedule. If one does not exist, every grant since inception has to be valued and booked retroactively, which is slow and expensive at exactly the wrong moment.
The second is Series A diligence. Institutional investors expect financial statements prepared on an accrual basis, and sophisticated ones will notice a cap table full of option grants sitting next to an income statement with zero compensation expense for them. The gap signals that the books are not investor-grade yet.
The third is simply growing up. Once a company reports GAAP results to a board every quarter, stock comp belongs in those numbers. Teams that run a disciplined month-end close treat the stock comp entry as one more recurring journal entry, posted monthly from a schedule, rather than a year-end scramble. The earlier that habit starts, the smaller the cleanup ever gets.
How ASC 718 Works, Minus the Exam Prep
ASC 718 is the section of US GAAP that governs share-based payment. The core rule is that equity awards to employees are compensation, and compensation is an expense. The only real questions are how much and over what period.
The "how much" is grant-date fair value. For restricted stock and RSUs, fair value is the value of a share on the grant date. For options, a share of stock and an option on that share are different instruments, so companies use an option pricing model, almost always Black-Scholes, to value the option itself. The model takes the current share value, the exercise price, expected term, volatility, and interest rates, and produces a fair value per option that is a fraction of the share price.
This is where the 409A valuation enters. The 409A sets the fair market value of common stock, which serves two jobs at once: it becomes the strike price for new grants, and it feeds the share-value input in the Black-Scholes calculation. The 409A is not itself the expense. A $0.40 409A value might produce a $0.25 fair value per option once the model runs. Auditors will also assess whether the 409A value is appropriate to use for ASC 718 purposes, so keep the valuation current and confirm the approach with your auditor and valuation provider.
The "over what period" is the vesting period, formally the requisite service period. For a standard time-based vesting schedule, companies typically recognize the expense straight-line from the grant date through the final vesting date. One guardrail applies: cumulative expense must at least equal the fair value of the portion actually vested at each reporting date. Straight-line on a standard four-year monthly grant satisfies this naturally, but graded or back-loaded schedules can force expense to run ahead of the straight-line pace. One more policy choice matters: forfeitures. ASC 718 lets a company either estimate how many awards will be forfeited up front or account for forfeitures as they occur. Most startups elect the as-they-occur approach because it is simpler, and it means expense reverses when someone leaves before vesting.
A Worked Expense Schedule
Numbers make this concrete. Suppose a startup hires an engineer and grants 100,000 options with a $0.40 strike price, equal to the current 409A value per share. The Black-Scholes model produces a grant-date fair value of $0.25 per option, so the total award is worth $25,000. The grant vests over four years with a one-year cliff, and the company recognizes expense straight-line.
The schedule looks like this. The figures are illustrative, not advice, and your own inputs will differ.
| Year | Options vested | Expense recognized | Cumulative expense |
|---|---|---|---|
| 1 | 25,000 at the cliff | $6,250 | $6,250 |
| 2 | 25,000 (monthly) | $6,250 | $12,500 |
| 3 | 25,000 (monthly) | $6,250 | $18,750 |
| 4 | 25,000 (monthly) | $6,250 | $25,000 |
Two details in that table trip people up. First, expense accrues during year one even though nothing has vested yet, because cliff vesting changes when shares are earned, not when service is rendered. Second, if the engineer leaves in month eleven, zero options vest, and under an as-they-occur forfeiture policy the $5,700 or so already booked reverses out. The expense follows service that actually leads to vesting.
Multiply this schedule across every grant in the option pool and you have the monthly stock comp entry: one debit to compensation expense, one credit to additional paid-in capital. Cap table platforms generate the underlying report; the finance team's job is posting it and tying it out each close.
Where Stock Comp Lands on the P&L
ASC 718 expense is not a single line item parked at the bottom of the income statement. It follows the people. An engineer's grant amortizes into research and development. A sales rep's grant lands in sales and marketing. Grants to finance, operations, and executives flow into general and administrative expense, and grants to support or infrastructure roles that sit in cost of revenue flow into COGS.
This allocation matters more than it first appears. Functional expense lines feed gross margin, R&D intensity, and the operating benchmarks investors compare across companies. A startup that dumps all stock comp into G&A quietly overstates gross margin and understates true R&D spend. It also distorts budget vs actuals reviews, because department owners see cost lines that do not reflect what their teams actually cost.
Once stock comp starts flowing monthly, expect it to surface in variance reviews. A big new-hire grant or an executive refresh can move a functional line noticeably in one month, which is exactly the kind of movement a flux analysis should catch and explain before the board asks.
The "It's Non-Cash, So Ignore It" Trap
Here is the conversation that goes wrong. A founder reports monthly burn to the board using the bank account delta. The GAAP income statement shows a materially larger net loss because stock comp is now booked. Someone asks why the numbers disagree, and the answer "stock comp is non-cash, so we ignore it" lands badly, because half-right answers about your own financials erode confidence fast.
The accurate version has two halves. Yes, stock comp never touches the bank account, which is why it is added back in the operating section of the cash flow statement and why cash burn rate is unaffected. And no, it is not ignorable, because it is a real cost paid in ownership instead of cash. Every vested grant transfers a slice of the company from existing holders to employees. Run a few grant scenarios through a startup equity dilution calculator and the cost becomes visible in percentage terms, the same way stacked SAFEs become visible at conversion in a SAFE-heavy cap table.
The clean practice is to report both views on purpose. Show GAAP net loss with stock comp in it, show cash burn with a clear reconciliation, and never present an adjusted number without labeling what was removed. Board reporting that builds trust is mostly this: the same numbers every month, defined the same way, with the bridges shown.
Booking It Without Drama
Operationally, stock comp is one of the easier recurring entries once the pieces are in place. The inputs are the grant records and expense report from the cap table platform, a current 409A valuation, and board consents matching the grants. The monthly routine is to pull the expense report, post the journal entry by function, and reconcile the cumulative balance to additional paid-in capital.
The failure mode is treating it as an annual event. Backfilling twelve months of grants at year-end means restating monthly results the board already saw, and it usually surfaces messier problems, like grants issued before the board approved them or a stale 409A. Folding the entry into the standard close checklist, alongside payroll and accruals, keeps every month final when it closes. If the close itself is the bottleneck, financial close software built for small teams solves that problem before it compounds.
This is the model Futureproof is built around. Vic, our bookkeeping agent, posts recurring entries like stock comp from your schedule and keeps the close moving, while Nia assembles board reporting that shows GAAP results and cash burn side by side. The whole six-agent finance team is $1,000 per month flat. Start with Futureproof and the first close with stock comp in it looks like every close after.
FAQ
When does a startup have to start recording stock compensation expense?
Technically, GAAP requires it from the first grant. Practically, most startups start booking it when they first need GAAP financial statements that someone else will rely on, meaning a first audit, Series A diligence, or formal board reporting. Starting earlier is cheap; reconstructing years of grants later is not.
Is stock-based compensation a cash expense?
No. It reduces GAAP net income on the income statement but never touches cash, so it is added back in the operating section of the cash flow statement. The real cost shows up as dilution, since vested awards shift ownership from existing shareholders to employees.
How is the expense different for options versus RSUs?
Both are measured at grant-date fair value and expensed over vesting. The difference is measurement: an RSU's fair value is simply the share value on the grant date, while an option must be valued with a pricing model like Black-Scholes, which produces a per-option value well below the share price.
Does the 409A valuation determine the expense amount?
Not directly. The 409A establishes the fair market value of common stock, which sets the strike price for new options and feeds the share-price input of the Black-Scholes model. The expense comes from the model output, so a $0.40 share value can produce a $0.25 per-option expense. Confirm the valuation approach with your auditor and valuation provider.
What about ISOs versus NSOs?
The ASC 718 book expense is the same either way; the distinction is tax. At a high level, ISOs can defer employee tax until sale if holding requirements are met, while NSOs create ordinary income at exercise and generally give the company a tax deduction. The ISO fact that actually burns employees: the spread at exercise is an alternative minimum tax preference item, so a large ISO exercise can trigger AMT even when no shares are sold. And for early-exercise or restricted stock, an 83(b) election must be filed within 30 days, with no extensions. The tax treatment is fact-specific, so route those questions to a tax advisor rather than the accounting schedule.
